Abstract:BackgroundDrug-target interaction (DTI) is a vital drug design strategy that plays a significant role in many processes of complex diseases and cellular events. In the face of challenges such as extensive protein data and experimental costs, it is suggested to apply bioinformatics approaches to exploit potential interactions to design new targeted medications. Different data and interaction types bring difficulties to study involving incompatible and heterology formats. The analysis of drug-target interactions in a comprehensive and unified model is a significant challenge.MethodHere, we propose a general method for predicting interactions between small-molecule drugs and protein targets, Large-scale Drug target Screening Convolutional Neural Network (LDS-CNN), which used unified encoding to achieve the calculation of the different data formats in an integrated model to realize feature abstraction and potential object prediction.ResultOn 898,412 interaction data involving 1683 small-molecule compounds and 14,350 human proteins from 8.8 billion records, the proposed method achieved an area under the curve (AUC) of 0.96, an area under the precision-recall curve (AUPRC) of 0.95, and an accuracy of 90.13%. The experimental results illustrated that the proposed method attained high accuracy on the test set, indicating its high predictive ability in drug-target interaction prediction. LDS-CNN is effective for the prediction of large-scale datasets and datasets composed of data with different formats.ConclusionIn this study, we propose a DTI prediction method to solve the problems of unified encoding of large-scale data in multiple formats. It provides a feasible way to efficiently abstract the features among different types of drug-related data, thus reducing experimental costs and time consumption. The proposed method can be used to identify potential drug targets and candidates for the treatment of complex diseases. This work provides a reference for DTI to process large-scale data and different formats with deep learning methods and provides certain suggestions for future research.

Drug - Target Interaction Prediction with a Deep-Learning-based Model.

Deep learning-based transcriptome data classification for drug-target interaction prediction

Deep-Learning-Based Drug-Target Interaction Prediction.

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Improved Prediction Of Drug-Target Interactions Based On Ensemble Learning With Fuzzy Local Ternary Pattern

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

Predicting Drug-Target Interaction Via Wide And Deep Learning

LDS-CNN: a deep learning framework for drug-target interactions prediction based on large-scale drug screening

Efficient Deep Model Ensemble Framework for Drug-Target Interaction Prediction

A Drug Target Interaction Prediction Based on LINE-RF Learning

Novel deep learning-based transcriptome data analysis for drug-drug interaction prediction with an application in diabetes

Dti-Rcnn: New Efficient Hybrid Neural Network Model To Predict Drug-Target Interactions

Recent Advances in the Machine Learning-Based Drug-Target Interaction Prediction

BN-DTI: A Deep Learning Based Sequence Feature Incorporating Method for Predicting Drug-Target Interaction

Drug-target interactions prediction via deep collaborative filtering with multiembeddings

Prediction of Drug-target Interactions from Heterogeneous Information Network Based on LINE Embedding Model

Predicting drug-target interactions from drug structure and protein sequence using novel convolutional neural networks

DrugAI: a multi-view deep learning model for predicting drug-target activating/inhibiting mechanisms

Prediction of Drug-Target Interactions from Multi-Molecular Network Based on LINE Network Representation Method

Identifying potential drug-target interactions based on ensemble deep learning